Menu
ncarol.com
  • Home
  • Business
  • Real Estate
  • Health
  • Non-profit
  • Services
  • Music
  • Education
  • Beauty
ncarol.com

Matt Stuckert Joins Lineus Medical Board of Directors
ncarol.com/10289483

Trending...
  • Terizza Forms Strategic Collaboration with UC San Diego to Pioneer Next-Generation Distributed AI Infrastructure
  • Crunchbase Ranks Phinge Founder & CEO Robert DeMaio #1 Globally. Meet him in Las Vegas-Week of CES to Learn About Netverse, Patented App-less Platform
  • Peter J. D'Arruda Founder of Capital Financial Joins Tom Hegna on the Podcast "Financial Freedom with Tom Hegna"
Matt Stuckert SafeBreak Vascular Lineus Medical
FAYETTEVILLE, Ark. - ncarol.com -- Lineus Medical is pleased to announce the appointment of Matt Stuckert to its Board of Directors. Stuckert was previously a member of the Lineus Technical Advisory Board.  Stuckert brings over a decade of sales leadership experience in the vascular access space, and has held key roles at Magnolia Medical, Becton Dickinson, CareFusion, Cardinal Health, Enturia, and Venetec.. Throughout his career, he has successfully built and led sales teams, and has driven commercial growth, particularly in the adoption of novel new vascular technologies.

His expertise in sales strategy and business development will be instrumental in guiding Lineus Medical's continued success. With a deep understanding of the vascular access market, Stuckert's knowledge will help support the growth of the company's flagship product, SafeBreak Vascular. Stuckert commented, "I am excited to join Lineus Medical's Board of Directors and contribute to the company's growth. SafeBreak Vascular is a game-changing vascular access device that directly addresses IV complications and improves patient experience, both critical issues in hospitals. I look forward to leveraging my experience to help expand SafeBreak's adoption and support the company's mission of improving IV care."

More on ncarol.com
  • Children Rising Appoints Marshelle A. Wilburn as New Executive Director
  • Fairmint CEO Joris Delanoue Elected General Director of the Canton Foundation
  • Sleep Basil Mattress Co.'s Debuts New Home Page Showcasing Performance Sleep Solutions for Active Denver Lifestyles
  • Bent Danholm Joins The American Dream TV as Central Florida Host
  • Ability 2 Play Hosts Free Demo Day for Families in Raleigh/Garner Area

Vance Clement, CEO of Lineus Medical said, "Matt Stuckert's extensive experience in vascular access sales and marketing makes him a valuable addition to our Board. His insights will be instrumental as we expand SafeBreak Vascular's presence in hospitals nationwide. We are excited to have him join our board as we continue to revolutionize what vascular access care looks like."

SafeBreak Vascular is the only break-away device for IV lines clinically proven to reduce IV complications¹. When a harmful force is placed on the line, SafeBreak intentionally separates to remove the damaging force and protect the patient's IV. When SafeBreak separates, valves on both ends of the device close, preventing medicine spills from the pump and blood loss from the patient. To replace SafeBreak, each component is unthreaded from the line, a new sterile SafeBreak is installed, and the patient's infusion is restarted. Patients avoid additional needlesticks, nurses save time, and hospitals save money.1

About Lineus Medical

Lineus Medical is the developer of break-away technology proven to reduce IV restarts and complications¹. Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn.

References:
1. Data on File

Contact
Vance Clement
***@lineusmed.com


Source: Lineus Medical
Filed Under: Health

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • MEX Finance meluncurkan platform keuangan berbasis riset yang berfokus pada data, logika, dan efisiensi pengambilan keputusan investasi
  • From MelaMed Wellness to Calmly Rooted: A New Chapter in Functional Wellness
  • New Angles US Group Founder Alexander Harrington Receives Top U.S. Corporate Training Honor and Leads Asia-Pacific Engagements in Taiwan
  • UK Financial Ltd Board of Directors Establishes Official News Distribution Framework and Issues Governance Decision on Official Telegram Channels
  • UK Financial Ltd Sets Official 30-Day Conversion Deadline for Three Exchange Listed Tokens Ahead of Regulated Upgrade
  • New Jersey Therapy and Life Coaching Unveils Original Dan Fenelon Mural in Voorhees New Jersey Therapy Office
  • Kentucky Judges Ignore Evidence, Prolong Father's Ordeal in Baseless Case
  • Contracting Resources Group Receives 2025 HIRE Vets Platinum Medallion Award from the U.S. Department of Labor
  • Peter J. D'Arruda Founder of Capital Financial Joins Tom Hegna on the Podcast "Financial Freedom with Tom Hegna"
  • Crunchbase Ranks Phinge Founder & CEO Robert DeMaio #1 Globally. Meet him in Las Vegas-Week of CES to Learn About Netverse, Patented App-less Platform
  • Run the Diamond Releases New Winter Workout Album for Baseball and Softball Athletes
  • IODefi Introduces New Web3 Infrastructure Framework as XRP Ledger Development Gains Global Attention
  • Terizza Forms Strategic Collaboration with UC San Diego to Pioneer Next-Generation Distributed AI Infrastructure
  • EnergyStrat Launches Global LNG Risk Outlook 2025–2030
  • LTL Claims Ratio Index – Update 3Q25
  • Strong Revenue Gains, Accelerating Growth, Strategic Hospital Expansion & Uplisting Advancements: Cardiff Lexington Corporation (Stock Symbol: CDIX)
  • Billion Strong Foundation Upgrades 3X Skills + Career Finder and New AI Impact Engine
  • Holiday Decorations Most Likely to Cause Injuries
  • UK Financial Ltd Confirms Official Corporate Structure of the Maya Preferred Project and Its Dual-Class Token System
  • CCHR Florida Joins Global Call to Ban Electroshock Treatment, Citing New Evidence of Widespread Patient Harm
_catLbl0 _catLbl1

Popular on ncarol.com

  • Liquidity Aggregation: US-Registered JHKXWL Integrates AI Analytics for Brazilian and Global Institutional Traders - 884
  • Slotozilla's Q3 2025: SBC Lisbon Outcomes and Partnership Expansion
  • Cut Costs & Boost Profits with the First Major Upgrade in 30 YEARS Replacing Rotary Lasers and Historic Clear Tube Altimeter Bubbles
  • Dispelling Holiday Suicide Myth: CDC Data Shows Suicide Rates Lowest in December; International Survivors of Suicide Day Emphasizes Need for Action
  • BumblebeeSmart Introduces Rounded Busy Board Set for Preschoolers
  • Own 327 Acres of American Prime Real Estate with 2 Miles Waterfront Worth In Millions for Just $7 — Worldwide Raffle Launched
  • Lineus Medical Receives Patent for SafeBreak® Vascular Generation 2
  • Sons of Liberty Museum Unveils "America at 250" Mobile Exhibit on Veterans Day 2025
  • Stratum Nutrition's OVOLUX™ Named 2025 "Collagen Ingredient of the Year" by Beauty Innovation Awards
  • The Kryder Law Group, LLC Report Reveals Commercial Air Travel Is Safer Than You Think

Similar on ncarol.com

  • NAFMNP Awarded USDA Cooperative Agreement to Continue MarketLink Program Under FFAB
  • VSee Health (N A S D A Q: VSEE) Secures $6.0M At-Market Investment, Accelerates Expansion as Revenues Surge
  • Fairmint CEO Joris Delanoue Elected General Director of the Canton Foundation
  • Artificial Intelligence Leader Releases Children's Book on Veterans Day
  • CCHR Documentary Probes Growing Evidence Linking Psychiatric Drugs to Violence
  • Tokenized Real-World Assets: Iguabit Brings Institutional Investment Opportunities to Brazil
  • MEX Finance meluncurkan platform keuangan berbasis riset yang berfokus pada data, logika, dan efisiensi pengambilan keputusan investasi
  • From MelaMed Wellness to Calmly Rooted: A New Chapter in Functional Wellness
  • New Jersey Therapy and Life Coaching Unveils Original Dan Fenelon Mural in Voorhees New Jersey Therapy Office
  • Contracting Resources Group Receives 2025 HIRE Vets Platinum Medallion Award from the U.S. Department of Labor
Copyright © 2025 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute